USPTO serial 88772796
TWIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 18, 2025
- Examiner
- ADEYIGA, ADETAYO JANET
- Law office
- TMEG LAW OFFICE 109
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TWIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Menlo Park, CA, US
Mountain View, CA, US
Mountain View, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Connie L. Ellerbach, Esq.
Connie L. Ellerbach, Esq. Fenwick & West LLP801 California StreetSilicon Valley CenterMountain View, CA 94041-1990Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for monitoring and treating diabetes and other diseases; dietary and nutritional supplements; dietary and nutritional supplements for monitoring and treating diabetes and other diseases; dietetic foods adapted for medical use; medical diagnostic test media in the form of strips, threads, and patches for blood and body fluid analysis for secondary testing or detection of nucleic acids, nucleic acid sequences, specific to metabolic function related to the holistic metabolic treatment approach; diagnostic test patches for testing glucose levels, blood pressure, and ketone levels; transdermal patches for measuring and monitoring glucose levels | ACTIVE | — |
| 009 | Downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of medical data and information, excluding medical data and information related to genetics, nucleic acid sequence, and genotype, but not excluding medical data and information related to genetic markers specific to diabetes and other metabolic disorders; downloadable mobile applications for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of medical data and information, excluding medical data and information related to genetics, nucleic acid sequence, and genotype, but not excluding medical data and information related to genetic markers specific to diabetes and other metabolic disorders; downloadable computer software for monitoring health and wellness, providing health and wellness notifications, gathering, analyzing, transmitting, and sharing health data and information, and providing treatment and therapeutic recommendations, excluding data and treatment and therapeutic recommendations related to genetics, nucleic acid sequence, and genotype; downloadable mobile applications for monitoring health and wellness, providing health and wellness notifications, gathering, analyzing, transmitting, and sharing health data and information, and providing treatment and therapeutic recommendations, excluding data and treatment and therapeutic recommendations related to genetics, nucleic acid sequence and genotype, but not excluding data and treatment and therapeutic recommendations related to genetic markers specific to diabetes and other metabolic disorders; downloadable artificial intelligence software for making medical recommendations and changes for patients, generating specific and customized nutritional recommendations for patients, predicting glucose levels, excluding recommendations based on genetics, nucleic acid sequence and genotype data, but not excluding recommendations based on genetic markers specific to diabetes and other metabolic disorders, and providing doctor and patient alerts; downloadable artificial intelligence mobile applications for making medical recommendations and changes for patients, generating specific and customized nutritional recommendations for patients, predicting glucose levels and other health data points, detecting and analyzing disease indicators, excluding recommendations and predictions based on genetics, nucleic acid sequence and genotype data, but not excluding recommendations and predictions based on genetic markers specific to diabetes and other metabolic disorders, and providing doctor and patient alerts; downloadable computer software for communicating with health and wellness coaches and medical professionals; downloadable mobile applications for communicating with health and wellness coaches and medical professionals; downloadable computer software for accessing and subscribing to health and wellness services and managing those subscriptions; downloadable mobile applications for accessing and subscribing to health and wellness services and managing those subscriptions; downloadable computer software for entering, accessing, tracking, monitoring, and generating health and medical information and reports, excluding information and reports relating to genetics, nucleic acid sequence and genotype data, but not excluding information and reports relating to genetic markers specific to diabetes and other metabolic disorders; downloadable mobile applications for entering, accessing, tracking, monitoring, and generating health and medical information and reports, excluding information and reports related to genetics, nucleic acid sequence and genotype data, but not excluding information and reports relating to genetic markers specific to diabetes and other metabolic disorders; electronic scales; wearable activity trackers; wearable computers in the nature of smartwatches; wearable video display monitors; downloadable educational course materials in the fields of health, wellness, and the operation of software and devices in those fields, excluding data related to genetics, nucleic acid sequence, and genotype, but not excluding data related to genetic markers specific to diabetes and other metabolic disorders | ACTIVE | — |
| 010 | Medical devices and apparatus with embedded artificial intelligence software for making medical recommendations and changes for patients, generating specific and customized nutritional recommendations for patients, predicting glucose levels and other health data points, detecting and analyzing disease indicators, and providing doctor and patient alerts; wearable monitors used to measure biometric data, glucose levels, blood pressure levels, and ketone levels for medical use; wearable monitors used to measure biometric data, glucose levels, blood pressure levels, and ketone levels for medical use with smartwatch features; electronic bio sensors for medical use for measuring glucose levels, blood pressure, and ketone levels; glucose meters; medical devices and meters for measuring blood pressure; medical devices and meters for measuring ketone; blood testing apparatus; medical test kits for diabetes monitoring for medical and home use | ACTIVE | — |
| 037 | Technical support services, namely, troubleshooting in the nature of repair of medical equipment and medical devices | ACTIVE | — |
| 041 | Educational services, namely, conducting classes, seminars, and educational programs in the fields of health, wellness, and the operation and use of software and devices in those fields; training services in the fields of health, wellness, and the operation and use of software and devices in those fields; life coaching services in the field of health and wellness; health and wellness coaching | ACTIVE | — |
| 042 | Providing online non-downloadable software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of medical data and information, excluding medical data and information related to genetics, nucleic acid sequence, and genotype, but not excluding medical data and information related to genetic markers specific to diabetes and other metabolic disorders; software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage, and sharing of medical data and information, excluding medical data and information related to genetics, nucleic acid sequence, and genotype, but not excluding medical data and information related to genetic markers specific to diabetes and other metabolic disorders; providing online non-downloadable artificial intelligence software for making medical recommendations and changes for patients, generating specific and customized nutritional recommendations for patients, predicting glucose levels and other health data points, detecting and analyzing disease indicators, excluding recommendations and predictions based on genetics, nucleic acid sequence, and genotype data, but not excluding recommendations and predictions based on genetic markers specific to diabetes and other metabolic disorders, and providing doctor and patient alerts; software as a service (SAAS) services featuring artificial intelligence software for making medical recommendations and changes for patients, generating specific and customized nutritional recommendations for patients, predicting glucose levels and other health data points, detecting and analyzing disease indicators, excluding recommendations and predictions based on genetics, nucleic acid sequence, and genotype data, but not excluding recommendations and predictions based on genetic markers specific to diabetes and other metabolic disorders, and providing doctor and patient alerts; providing online non-downloadable software for monitoring health and wellness, providing health and wellness notifications, gathering, analyzing, transmitting, and sharing health data and information, and providing treatment and therapeutic recommendations, excluding data and treatment and therapeutic recommendations related to pharmaceuticals and genetics, but not excluding data and treatment and therapeutic recommendations related to genetic markers specific to diabetes and other metabolic disorders; software as a service (SAAS) services featuring software for monitoring health and wellness, providing health and wellness notifications, gathering, analyzing, transmitting, and sharing health data and information, and providing treatment and therapeutic recommendations, excluding data and treatment and therapeutic recommendations related to pharmaceuticals and genetics; providing online non-downloadable software for communicating with health and wellness coaches and medical professionals; software as a service (SAAS) services featuring software for communicating with health and wellness coaches and medical professionals; providing online non-downloadable software for entering, accessing, tracking, monitoring, and generating health and medical information and reports, excluding information and reports related to and based on genetics, nucleic acid sequence and genotype data, but not excluding information and reports related to and based on genetic markers specific to diabetes and other metabolic disorders; software as a service (SAAS) services featuring software for entering, accessing, tracking, monitoring, and generating health and medical information and reports, excluding information and reports related to and based on genetics, nucleic acid sequence and genotype data, but not excluding information and reports related to and based on genetic markers specific to diabetes and other metabolic disorders; providing an interactive web site featuring technology that enables users to access and subscribe to health and wellness services and manage those subscriptions; providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports, excluding health and medical information and reports based on genetics, nucleic acid sequence, and genotype data, but not excluding health and medical information and reports based on genetic markers specific to diabetes and other metabolic disorders; providing an interactive website featuring artificial intelligence technology that allows users to monitor and analyze medical data, excluding medical data related to genetics, nucleic acid sequence, and genotype, but not excluding medical data related to genetic markers specific to diabetes and other metabolic disorders, and subsequently makes recommendations and changes for patients, generates specific and customized nutritional recommendations for patients, predicts glucose levels and other health data points, detects and analyzes disease indicators, excluding recommendations, detection, and analysis based on genetics, nucleic acid sequence, and genotype data, but not excluding recommendations, detection, and analysis based on genetic markers specific to diabetes and other metabolic disorders, and provides doctor and patient alerts; design and development of hardware, software, and devices in the fields of medicine and health monitoring, excluding hardware, software, and devices in the fields of medicine and health monitoring that use genetics, nucleic acid sequence, and genotype data, but not excluding hardware, software, and devices in the fields of genetic markers specific to diabetes and other metabolic disorders; technical support services, namely, troubleshooting in the nature of diagnosing problems with medical computer software and medical equipment; technical support services, namely, services for the updating, maintenance, installation, customization, and repair of medical computer software; information, advisory, and consulting services relating to the aforesaid | ACTIVE | — |
| 044 | Medical services, excluding services related to and using genetics, nucleic acid sequence, and genotype information, but not excluding services related to and using genetic markers specific to diabetes and other metabolic disorders; home health care services; nutrition counseling; health monitoring services for medical diagnosis and treatment purposes; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes, excluding data related to genetics, nucleic acid sequence, and genotype; information, advisory, and consulting services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Twin Health, Inc.
- Other trademarks owned by Twin Health, Inc.
- Other trademarks owned by Twin Health, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TWIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 5, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 5, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 5, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 5, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 18, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 18, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 28, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 28, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 1, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 30, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 28, 2024 | IUAF | USE AMENDMENT FILED | — |
| Aug 28, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 19, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 17, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 17, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 25, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 23, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 23, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 23, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 28, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 19, 2023 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jan 19, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jan 19, 2023 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Nov 5, 2021 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jun 10, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 11, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 11, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 21, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 6, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2020 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 13, 2020 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 13, 2020 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 17, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 29, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 28, 2020 | NWAP | NEW APPLICATION ENTERED | — |